Correlation Between Medtronic PLC and Revolution Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medtronic PLC and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medtronic PLC and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medtronic PLC and Revolution Medicines, you can compare the effects of market volatilities on Medtronic PLC and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medtronic PLC with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medtronic PLC and Revolution Medicines.

Diversification Opportunities for Medtronic PLC and Revolution Medicines

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Medtronic and Revolution is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Medtronic PLC and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Medtronic PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medtronic PLC are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Medtronic PLC i.e., Medtronic PLC and Revolution Medicines go up and down completely randomly.

Pair Corralation between Medtronic PLC and Revolution Medicines

Considering the 90-day investment horizon Medtronic PLC is expected to under-perform the Revolution Medicines. But the stock apears to be less risky and, when comparing its historical volatility, Medtronic PLC is 2.36 times less risky than Revolution Medicines. The stock trades about -0.02 of its potential returns per unit of risk. The Revolution Medicines is currently generating about 0.22 of returns per unit of risk over similar time horizon. If you would invest  4,156  in Revolution Medicines on September 3, 2024 and sell it today you would earn a total of  1,629  from holding Revolution Medicines or generate 39.2% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Medtronic PLC  vs.  Revolution Medicines

 Performance 
       Timeline  
Medtronic PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medtronic PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Medtronic PLC is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.
Revolution Medicines 

Risk-Adjusted Performance

17 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady primary indicators, Revolution Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.

Medtronic PLC and Revolution Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medtronic PLC and Revolution Medicines

The main advantage of trading using opposite Medtronic PLC and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medtronic PLC position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.
The idea behind Medtronic PLC and Revolution Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas